2

I founded alot of sites talk about this news a research team from Hong Kong university invents universal antibody drug for hiv-1 and they tested that in mice news source.

Basically, they propose an engineered tandem bispecific broadly neutralizing antibody (bs-bnAb) as an innovative product for HIV-1 prophylactic and therapeutic interventions.

How promising is this recent research?

| improve this question | |
  • 2
    The study does exist and is available here. I'm interested to hear what others think about the significance of this study. But the researchers themselves point out: It should be noted that HIV-1–infected humanized NSG-HuPBL mice do not fully represent infected patients, although this model has been widely used to study bnAb-based HIV-1 immunotherapy To me, this seems more like a new direction of research than anywhere near to a drug. – Narusan Jun 4 '18 at 13:02

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service, privacy policy and cookie policy

Browse other questions tagged or ask your own question.